[{"Assets_0_Q2_USD":333940433.0,"CommonStockSharesOutstanding_0_Q2_shares":94665718.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":148698255.0,"NetIncomeLoss_1_Q2_USD":23896982.0,"NetIncomeLoss_2_Q2_USD":35934235.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":94155407.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":92623615.0,"StockholdersEquity_0_Q2_USD":201195424.0,"EarningsPerShareBasic_1_Q2_USD":0.25,"EarningsPerShareBasic_2_Q2_USD":0.39,"Ticker":"ARWR","CIK":"879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","OfficialName":"Arrowhead Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4797362481.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]